Table 4.
Favorable outcome | Adverse outcome | p | |
---|---|---|---|
Blood laboratory tests | |||
White blood cell count (x 10^9/L) | 7.59 ± 4.55 | 7.30 ± 3.42 | 0.658 |
White blood cell count < 4000 (x 10^9/L) |
12 (8.8%) | 6 (12%) | 0.382 |
Hemoglobin (g/L) | 13.23 ± 1.84 | 12.32 ± 2.03 | 0.022 |
Hemoglobin < 10 g/L | 5 (3.3%) | 6 (12%) | 0.011 |
Platelet count (x 10^9/L) | 216.19 ± 80.69 | 181.74 ± 70.21 | 0.007 |
Platelet count < 100 (x 10^9/L) | 6 (4%) | 6 (12%) | 0.076 |
Lymphocyte count (x 10^9/L) | 1.08 ± 0.55 | 0.77 ± 0.38 | 0.003 |
INR | 1.25 ± 0.42 | 1.38 ± 0.36 | 0.453 |
D-dimer (ng/mL) | 857.72 ± 471.35 | 1905.14 ± 1945.89 | 0.003 |
Alanine aminotransferase (U/L) | 40.46 ± 28.59 | 33.79 ± 28 | 0.296 |
Creatine kinase (U/L) | 354.27 ± 1256.58 | 196.76 ± 211.92 | 0.437 |
Lactate dehydrogenase (U/L) | 310.41 ± 109.99 | 393.2 ± 210.97 | 0.022 |
Lactate dehydrogenase > 300 U/L* | 24 (18,4%) | 20 (54%) | <0.001 |
Ferritin (ng/mL) | 1309.39 ± 1618.34 | 2993.55 ± 4026.43 | 0.001 |
Ferritin > 500 ng/mL | 88 (58.6%) | 23 (46%) | 0.809 |
Ferritin >1000 ng/mL | 56 (37.3%) | 17 (24%) | 0.241 |
Ferritin >3000 ng/mL | 6 (4%) | 10 (20%) | <0.001 |
CRP (mg/L) | 119.41 ± 86.83 | 119.7 ± 86.03 | 0.985 |
INR: international normalized ratio; CRP: C reactive protein.
* data evaluated on a total of 167 patients.